Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls
(2011) In Diabetes/Metabolism Research & Reviews 27(8). p.737-745- Abstract
- Background Type 1 diabetes (T1D) is a cell-mediated autoimmune disease characterized by destruction of the pancreatic islet cells. The use of cryopreserved cells is preferable to the use of freshly isolated cells to monitor clinical trials to decrease assay and laboratory variability. Methods The T-Cell Workshop Committee of the Immunology of Diabetes Society compared two widely accepted T-cell freezing protocols (warm and cold) to freshly isolated peripheral blood mononuclear cells from patients with T1D and controls in terms of recovery, viability, cell subset composition, and performance in functional assays currently in use in T1D-related research. Nine laboratories participated in the study with four different functional assays... (More)
- Background Type 1 diabetes (T1D) is a cell-mediated autoimmune disease characterized by destruction of the pancreatic islet cells. The use of cryopreserved cells is preferable to the use of freshly isolated cells to monitor clinical trials to decrease assay and laboratory variability. Methods The T-Cell Workshop Committee of the Immunology of Diabetes Society compared two widely accepted T-cell freezing protocols (warm and cold) to freshly isolated peripheral blood mononuclear cells from patients with T1D and controls in terms of recovery, viability, cell subset composition, and performance in functional assays currently in use in T1D-related research. Nine laboratories participated in the study with four different functional assays included. Results The cold freezing method yielded higher recovery and viability compared with the warm freezing method. Irrespective of freezing protocol, B cells and CD8+ T cells were enriched, monocyte fraction decreased, and islet antigen-reactive responses were lower in frozen versus fresh cells. However, these results need to take in to account that the overall response to islet autoantigens was low in some assays. Conclusions In the current study, none of the tested T-cell functional assays performed well using frozen samples. More research is required to identify a freezing method and a T-cell functional assay that will produce responses in patients with T1D comparable to responses using fresh peripheral blood mononuclear cells. Copyright (C) 2011 John Wiley & Sons, Ltd. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2378564
- author
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- T cells, proliferation, ELISPOT, tetramer, cryopreservation, CFSE, islet, antigens, type 1 diabetes
- in
- Diabetes/Metabolism Research & Reviews
- volume
- 27
- issue
- 8
- pages
- 737 - 745
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- wos:000300108000004
- scopus:80755176918
- pmid:22069253
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.1245
- language
- English
- LU publication?
- yes
- id
- 8aa2f865-c71d-4423-9438-7fdd4f4e41b4 (old id 2378564)
- date added to LUP
- 2016-04-01 10:43:40
- date last changed
- 2022-01-26 01:58:23
@article{8aa2f865-c71d-4423-9438-7fdd4f4e41b4,
abstract = {{Background Type 1 diabetes (T1D) is a cell-mediated autoimmune disease characterized by destruction of the pancreatic islet cells. The use of cryopreserved cells is preferable to the use of freshly isolated cells to monitor clinical trials to decrease assay and laboratory variability. Methods The T-Cell Workshop Committee of the Immunology of Diabetes Society compared two widely accepted T-cell freezing protocols (warm and cold) to freshly isolated peripheral blood mononuclear cells from patients with T1D and controls in terms of recovery, viability, cell subset composition, and performance in functional assays currently in use in T1D-related research. Nine laboratories participated in the study with four different functional assays included. Results The cold freezing method yielded higher recovery and viability compared with the warm freezing method. Irrespective of freezing protocol, B cells and CD8+ T cells were enriched, monocyte fraction decreased, and islet antigen-reactive responses were lower in frozen versus fresh cells. However, these results need to take in to account that the overall response to islet autoantigens was low in some assays. Conclusions In the current study, none of the tested T-cell functional assays performed well using frozen samples. More research is required to identify a freezing method and a T-cell functional assay that will produce responses in patients with T1D comparable to responses using fresh peripheral blood mononuclear cells. Copyright (C) 2011 John Wiley & Sons, Ltd.}},
author = {{Brooks-Worrell, B. and Tree, T. and Mannering, S. I. and Durinovic-Bello, I. and James, E. and Gottlieb, P. and Wong, S. and Zhou, Z. and Yang, L. and Cilio, Corrado and Reichow, J. and Menart, B. and Rutter, R. and Schreiner, R. and Pham, M. and de Marquesini, L. Petrich and Lou, O. and Scotto, M. and Mallone, R. and Schloot, N. C.}},
issn = {{1520-7552}},
keywords = {{T cells; proliferation; ELISPOT; tetramer; cryopreservation; CFSE; islet; antigens; type 1 diabetes}},
language = {{eng}},
number = {{8}},
pages = {{737--745}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Diabetes/Metabolism Research & Reviews}},
title = {{Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls}},
url = {{http://dx.doi.org/10.1002/dmrr.1245}},
doi = {{10.1002/dmrr.1245}},
volume = {{27}},
year = {{2011}},
}